Synthesis and Preclinical Evaluation of Two Novel 68Ga-Labeled Bispecific PSMA/FAP-Targeted Tracers with 2-Nal-Containing PSMA-Targeted Pharmacophore and Pyridine-Based FAP-Targeted Pharmacophore
Open Access
Abstract
Some bispecific radiotracers have been developed to overcome the limitations of monospecific tracers and improve detection sensitivity for heterogeneous tumor lesions. Here, we aim to synthesize two bispecific tracers targeting prostate-specific membrane antigen (PSMA) and fibroblast activation protein (FAP), which are key markers expressed in prostate cancer. A pyridine-based FAP-targeted ligand was synthesized through multi-step organic synthesis and then connected to the 2-Nal-containing PSMA-targeted motif. The Ki(PSMA) values of Ga-complexed bispecific ligands, Ga-AV01084 and Ga-AV01088, were 11.6 ± 3.25 and 28.7 ± 6.05 nM, respectively, and the IC50(FAP) values of Ga-AV01084 and Ga-AV01088 were 10.9 ± 0.67 and 16.7 ± 1.53 nM, respectively. Both [68Ga]Ga-AV01084 and [68Ga]Ga-AV01088 enabled the visualization of PSMA-expressing LNCaP tumor xenografts and FAP-expressing HEK293T:hFAP tumor xenografts in PET images acquired at 1 h post-injection. However, the tumor uptake values from the bispecific tracers were still lower than those obtained from the monospecific tracers, PSMA-targeted [68Ga]Ga-PSMA-617 and FAP-targeted [68Ga]Ga-AV02070. Further investigations are needed to optimize the selection of linkers and targeted pharmacophores to improve the tumor uptake of bispecific PSMA/FAP tracers for prostate cancer imaging.Keywords
All Related Versions
Funding Information
- Canadian Institutes of Health Research (PJT-162243, PJT-180299, PJT-180300)
This publication has 38 references indexed in Scilit:
- Specific inhibition of fibroblast activation protein (FAP)-alpha prevents tumor progression in vitroAdvances in Medical Sciences, 2015
- In VivoRadioimaging of Bradykinin Receptor B1, a Widely Overexpressed Molecule in Human CancerCancer Research, 2015
- Extended Structure–Activity Relationship and Pharmacokinetic Investigation of (4-Quinolinoyl)glycyl-2-cyanopyrrolidine Inhibitors of Fibroblast Activation Protein (FAP)Journal of Medicinal Chemistry, 2014
- Prostate‐specific membrane antigen expression in tumor‐associated vasculature of breast cancersAPMIS, 2013
- Fibroblast activation protein expression by stromal cells and tumor-associated macrophages in human breast cancerHuman Pathology, 2013
- Identification of Selective and Potent Inhibitors of Fibroblast Activation Protein and Prolyl OligopeptidaseJournal of Medicinal Chemistry, 2013
- High expression of prostate-specific membrane antigen in the tumor-associated neo-vasculature is associated with worse prognosis in squamous cell carcinoma of the oral cavityLaboratory Investigation, 2012
- Heterogeneity of Prostate-Specific Membrane Antigen (PSMA) Expression in Prostate Carcinoma with Distant MetastasisPathology and Oncology Research, 2008
- Clinical Implications of Fibroblast Activation Protein in Patients with Colon CancerClinical Cancer Research, 2007
- Is prostate-specific membrane antigen a multifunctional protein?American Journal of Physiology-Cell Physiology, 2005